3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
10
Colorectal Neoplasms
10
Stomach Neoplasms
8
Colonic Neoplasms
7
Ovarian Neoplasms
3
Gastrointestinal Stromal Tumors
3
Liver Neoplasms
2
Kidney Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Venous Thrombosis
1
Urinary Incontinence
1
Surgical Wound Infection
1
Sexual Dysfunction, Physiological
1
Peritoneal Neoplasms
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Malignant Neoplasm of Transverse Colon
1
Locally Advanced Gastric Cancer
1
Liver Diseases
1
Inflammatory Bowel Diseases
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Erectile Dysfunction
1
Endometrial Neoplasms
1
Diverticulum
1
Colorectal Liver Metastasis
1
Cholecystolithiasis
1
Carcinoma, Pancreatic Ductal
1
Interventions
Cisplatin
28
Paclitaxel
19
Radiotherapy
17
Fluorouracil
13
Drug Therapy
12
camrelizumab
10
toripalimab
8
Carboplatin
8
Radiation
7
Capecitabine
7
Radiotherapy, Intensity-Modulated
6
sintilimab
5
S 1 (combination)
5
Esophagectomy
5
tislelizumab
4
nimotuzumab
4
apatinib
4
anlotinib
4
Irinotecan
4
Cetuximab
4
Afatinib
4
pembrolizumab
3
durvalumab
3
Vinorelbine
3
Positron Emission Tomography Computed Tomography
3
Oxaliplatin
3
Nivolumab
3
Immune Checkpoint Inhibitors
3
Docetaxel
3
Albumin-Bound Paclitaxel
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Esophageal Squamous Cell Carcinoma
×
Laparoscopy
×
Clear all
NCT02188615
2014-07-11
NACRFMIE
Taizhou Hospital
Phase 2
Unknown
120 enrolled